Brain tumors are particularly challenging malignancies, due to their location in a structurally
and functionally distinct part of the human body–the central nervous system (CNS). The CNS …

After the protocol-related indecisive clinical trial of Oxygent, a perfluorooctylbromide/
phospholipid nanoemulsion, in cardiac surgery, that often unduly assigned the observed …

The last two decades have seen the development of acoustically activated droplets, also
known as phase-change emulsions, from a diagnostic tool to a therapeutic agent. Through …

Nanodroplets–emerging phase-changing sonoresponsive materials–have attracted
substantial attention in biomedical applications for both tumour imaging and therapeutic …

In recent decades ultrasound-guided delivery of drugs loaded on nanocarriers has been the
focus of increasing attention to improve therapeutic treatments. Ultrasound has often been …

The advent of localization-based super-resolution ultrasound (SRUS) imaging creates a
vista for precision vasculature and hemodynamic measurements in brain science …

Continued advances in the field of ultrasound and ultrasound contrast agents have created
new approaches to imaging and medical intervention. Phase-shift perfluorocarbon droplets …

Phase change contrast agents (PCCAs) have been studied in the medical ultrasound field
for nearly three decades. Their ability to convert from a liquid core droplet to an acoustically …

Perfluorocarbon nanodroplets (PFCnDs) are sub-micrometer emulsions composed of a
surfactant-encased perfluorocarbon (PFC) liquid and can be formulated to transiently …

Breast cancer is a diverse and complex disease that remains one of the leading causes of
death among women. Novel, outside-of-the-box imaging and treatment methods are needed …